Millions of American families rely on FSAs, HSAs, and other tax-preferred accounts to help meet their basic healthcare needs, including the purchase of OTC medicines.
The Consumer Healthcare Products Association (CHPA) announced the election of three new members to the CHPA Board of Directors today during the association’s June board meeting.
The Consumer Healthcare Products Association board of directors today elected Deborah J. Mignucci, vice president, strategic accounts, WebMD to join the CHPA Educational Foundation board.
CHPA applauds New Hampshire for becoming the 35th state to adopt the real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx), a system used by retailers across the country to help prevent the illegal sale of pseudoephedrine.
CHPA applauds the U.S. House Ways and Means Health Subcommittee for today’s hearing, examining the benefits of consumer access to tax-preferred savings accounts, HSAs and FSAs.
The CHPA Educational Foundation today released findings from a study examining the common attitudes and behaviors of parents when administering pediatric over-the-counter (OTC) liquid medicines to young children.
Colorado Governor John Hickenlooper signed into law HB 1307, legislation prohibiting the sale of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM) to minors.
We are encouraged by the ongoing, bipartisan momentum behind this reform and look forward to seeing the legislation move forward in the House as well as the Senate.
Overwhelming scientific evidence shows that excess sun exposure without sunscreen increases the risk of developing skin cancer. Banning key ingredients in effective sunscreens will unnecessarily reduce the selection of safe and effective sunscreen products available.
CHPA applauds FDA for issuing a recent order in support of the full and complete switch from prescription to nonprescription status for the laxative active ingredient polyethylene glycol (PEG) 3350.
Today, the United States Senate Health, Education, Labor and Pensions (HELP) Committee approved S. 2315, the Over-the-Counter Drug Safety, Innovation, and Reform Act by a 22-1 vote.
